CompletedPhase 2NCT02441062

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

Studying Medulloblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sue O'Dorisio
Principal Investigator
Mary S O'Dorisio, MD, PhD
University of Iowa
Intervention
68Ga-DOTATOC PET/CT(drug)
Enrollment
122 enrolled
Eligibility
All sexes
Timeline
2015 – 2020

Study locations (1)

Collaborators

University of Iowa

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02441062 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma →

← Back to all trials